Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0.564. It has been cited 42 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.564
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R01CA236546-04
A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation
National Institutes of Health
Grant: 1P30AI060354-01
Harvard Medical School Center for AIDS Research
NIAID NIH HHS
Grant: P30 AI060354
NCI NIH HHS
Grant: R01 CA236546
Fields of Study
Keywords
Sustainable Development Goals